Carbidopa Levodopa (Sinemet, Aa-Levocarb) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Carbidopa Levodopa products are in shortage in Canada (4 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 30, 2026.
A combination medication used to treat the movement symptoms of Parkinson's disease.
Products affected
4 / 21
In shortage since
Nov 28, 2019
Est. full return
Nov 30, 2026
Reports on file
76
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MINT-LEVOCARB
25MG
250MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02457970 · since Dec 8, 2020, est. end Nov 30, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
TEVA-LEVOCARBIDOPA
25MG
100MG · TABLET · TEVA CANADA LIMITED
DIN 02244495 · since Nov 28, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-LEVOCARBIDOPA
25MG
100MG · TABLET · TEVA CANADA LIMITED
DIN 02244495 · since Dec 4, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-LEVOCARBIDOPA
10MG
100MG · TABLET · TEVA CANADA LIMITED
DIN 02244494 · since Mar 25, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-LEVOCARBIDOPA
25MG
250MG · TABLET · TEVA CANADA LIMITED
DIN 02244496 · since Feb 20, 2020, no end estimate · Disruption of the manufacture of the drug.
Resolved
MINT-LEVOCARB
10MG
100MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02457954 · ended Jan 5, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
AURO-LEVOCARB
25MG
100MG · TABLET · AURO PHARMA INC
DIN 02531607 · ended Apr 15, 2026 · Demand increase for the drug.
Resolved
AURO-LEVOCARB
10MG
100MG · TABLET · AURO PHARMA INC
DIN 02531593 · ended Apr 7, 2026 · Demand increase for the drug.
Resolved
AURO-LEVOCARB
25MG
250MG · TABLET · AURO PHARMA INC
DIN 02531615 · ended Apr 7, 2026 · Demand increase for the drug.
Resolved
AA-LEVOCARB CR
25MG
100MG · TABLET (EXTENDED-RELEASE) · AA PHARMA INC
DIN 02272873 · ended Mar 17, 2026 · Disruption of the manufacture of the drug.
Discontinued
TEVA-LEVOCARBIDOPA
25MG
250MG · TABLET · TEVA CANADA LIMITED
DIN 02244496
Resolved
MINT-LEVOCARB
25MG
100MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02457962 · ended Sep 20, 2024 · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Carbidopa Levodopa is currently affected by 4 active shortage reports filed with Health Canada by MINT PHARMACEUTICALS INC, TEVA CANADA LIMITED.
The reported causes are: requirements related to complying with good manufacturing practices; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Carbidopa Levodopa is classified under “DOPAMINERGIC AGENTS” (ATC N04BA02).
Recent changes
No changes recorded yet.
Common questions
What is Carbidopa Levodopa used for?
A combination medication used to treat the movement symptoms of Parkinson's disease.
When will Carbidopa Levodopa be back in stock in Canada?
The latest manufacturer estimate is Nov 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Carbidopa Levodopa in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.